Pay in 4 interest-free payments of $26.77 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Well-tolerated regimens of MSA-2 induced tumor regressions in mice bearing MC38 syngeneic tumors
InChi: InChI=1S/C36H46N8O3/c1-4-47-32-23-25(34(45)43-17-15-26(16-18-43)42-21-19-40(2)20-22-42)13-14-29(32)38-36-37-24-31-33(39-36)44(27-9-5-6-10-27)30-12-8-7-11-28(30)35(46)41(31)3/h7-8
InChi: InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8
InChiKey: YWTSCOORURJZBJ-UHFFFAOYSA-N
Zonisamide Sodium Catalog No.:M11295-2 Well-tolerated regimens of MSA-2 inducedZonisamide sodium (AD 810 sodium) is an inhibitor of zinc enzyme carbonic anhydrase (CA), with Kis of 35. 2 nM and 20. 6 nM for human mitochondrial isozyme hCA II and hCA V, respectively. Zonisamide sodium has antiepileptic activity. Zonisamide sodium can be used for the rsearch for epilepsy, seizures and Parkinson's disease. Product information CAS Number: 68291 98 5 Molecular Weight: 235. 22 Formula: C8H8N2NaO3S Chemical Name: (1,2 benzoxazol 3